Finance

Beta
Ask
Lists
APLLTD:NSE
Alembic Pharmaceuticals Ltd
747,75 INR
+0,59%
(+4,40) 1D
15 ივნ, 10:29:07 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APLLTD...
Open
750,00 INR
High
753,70 INR
Low
745,00 INR
Mkt. cap
146,98 მლრ.
Avg. vol.
196,56 ათ.
Volume
18,06 ათ.
P/E ratio
21,78
52-wk high
1 107,90 INR
52-wk low
635,80 INR
EPS
34,33 INR
Shares outstanding
188,50 მლნ.
No. of employees
17 ათ.
Open
750,00 INR
High
753,70 INR
Low
745,00 INR
Mkt. cap
146,98 მლრ.
Avg. vol.
196,56 ათ.
Volume
18,06 ათ.
P/E ratio
21,78
52-wk high
1 107,90 INR
52-wk low
635,80 INR
EPS
34,33 INR
Shares outstanding
188,50 მლნ.
No. of employees
17 ათ.
News stories
From sources across the web
marketscreener.com
marketscreener.com
·
34 წუთის წინ
S&P 500 index edged lower following Stockholm market close on Friday
Stocktwits
Stocktwits
·
1 საათის წინ
RKLB Stock Jumps Overnight: Rocket Lab Lines Up Record Launch Blitz After Nasdaq-100 Entry
www.marketscreener.com
www.marketscreener.com
·
46 წუთის წინ
Volati spinoff Salix Group begins trading today on Nasdaq Stockholm
Bloomberg.com
Bloomberg.com
·
14 საათის წინ
Equity Funding Squeeze Driven By AI Rally, SpaceX IPO Stretches Banks
About Alembic Pharmaceuticals Ltd
CEO-
Employees16,6 ათ.
Founded1907
Headquarters-
SectorPharmaceutical industry
Website-
Last report
15 მაი. 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
11,57 INR / 8,96 INR
+29,16%beat
Revenue / Est. (INR)
18,48 მლრდ. / 19,00 მლრდ.
-2,76%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
17,11 მლრდ.
19,10 მლრდ.
18,76 მლრდ.
18,48 მლრდ.
Cost of goods sold
4,07 მლრდ.
5,16 მლრდ.
5,29 მლრდ.
5,32 მლრდ.
Cost of revenue
4,07 მლრდ.
5,16 მლრდ.
5,29 მლრდ.
5,32 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,23 მლრდ.
4,38 მლრდ.
4,33 მლრდ.
4,39 მლრდ.
Operating expense
10,96 მლრდ.
11,55 მლრდ.
11,34 მლრდ.
11,76 მლრდ.
Total operating expenses
15,03 მლრდ.
16,71 მლრდ.
16,63 მლრდ.
17,08 მლრდ.
Operating income
2,08 მლრდ.
2,40 მლრდ.
2,13 მლრდ.
1,39 მლრდ.
Other non operating income
65,00 მლნ.
69,00 მლნ.
154,90 მლნ.
255,00 მლნ.
EBT including unusual items
1,90 მლრდ.
2,24 მლრდ.
1,61 მლრდ.
1,19 მლრდ.
EBT excluding unusual items
1,90 მლრდ.
2,24 მლრდ.
2,04 მლრდ.
1,43 მლრდ.
Income tax expense
364,80 მლნ.
400,00 მლნ.
295,40 მლნ.
-829,10 მლნ.
Effective tax rate
19,19%
17,88%
18,29%
-69,90%
Other operating expenses
5,99 მლრდ.
6,41 მლრდ.
6,21 მლრდ.
6,49 მლრდ.
Net income
1,54 მლრდ.
1,85 მლრდ.
1,33 მლრდ.
2,03 მლრდ.
Net profit margin
9,02%
9,67%
7,09%
10,97%
Earnings per share
7,85
9,40
8,51
11,57
Interest and investment income
-
-
-
-
Interest expense
-235,20 მლნ.
-242,30 მლნ.
-233,10 მლნ.
-225,60 მლნ.
Net interest expenses
-235,20 მლნ.
-242,30 მლნ.
-233,10 მლნ.
-225,60 მლნ.
Depreciation and amortization charges
737,70 მლნ.
760,70 მლნ.
801,20 მლნ.
885,90 მლნ.
EBITDA
2,72 მლრდ.
3,15 მლრდ.
2,78 მლრდ.
2,19 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer